In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Auris Surgical quietly raises $280mm in Series D round

Executive Summary

Minimally invasive surgical device firm Auris Surgical Robotics Inc. raised $280mm through a Series D round, according to a Form D filing and the company's website. Coatue Management led and was joined by 38 additional investors including Viking Global Investors, Section 32, and Partner Fund Management. Auris remains mum about most of its operations and projects, noting just that it is initially focusing on robotics-guided systems to treat lung cancer.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register